Immunocore Holdings plc Shares Outstanding (Cover Page)
Immunocore Holdings plc (IMCR) had Shares Outstanding (Cover Page) of 51.50 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 51.50M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 50.87M shares.
- 2026-01-31: Entity Common Stock, Shares Outstanding 50.70M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 50.53M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 51.50M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 50.87M shares 10-Q · filed 2026-05-06 |
| 2026-01-31 | 50.70M shares 10-K · filed 2026-02-25 |
| 2025-10-31 | 50.53M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 50.39M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 50.23M shares 10-Q · filed 2025-05-07 |
| 2025-01-31 | 50.07M shares 10-K · filed 2025-02-26 |
| 2024-10-31 | 50.03M shares 10-Q · filed 2024-11-06 |
| 2024-07-31 | 50.02M shares 10-Q · filed 2024-08-08 |
| 2024-01-31 | 49.82M shares 10-K · filed 2024-02-28 |
| 2022-12-31 | 48.09M shares 20-F · filed 2023-03-01 |
| 2021-12-31 | 43.86M shares 20-F · filed 2022-03-03 |
| 2020-12-31 | 31.78M shares 20-F · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |